Literature DB >> 32713118

Liver damage at admission is an independent prognostic factor for COVID-19.

Liu Ying Chen1, Hui Kuan Chu1, Tao Bai1, Sheng Jin Tu2, Yuan Wei2, Zhong Lin Li1, Li Lin Hu1, Rui Zhu3, Lei Zhang1, Chao Qun Han1, Li Xiao1, Qi He1, Jun Song1, Wei Hua Liu2, Qing Jing Zhu4, Hua Chen2, Ling Yang1, Xiao Hua Hou1.   

Abstract

OBJECTIVE: Abnormal liver function is a common form of extra-pulmonary organ damage in patients with coronavirus disease 2019 (COVID-19). Patients with severe COVID-19 have a higher probability and progression of liver injury than those without severe disease. We aimed to evaluate the prognosis of liver injury in patients with COVID-19.
METHODS: We retrospectively included 502 patients with laboratory-confirmed SARS-CoV-2 infection. Clinical features and survival of patients with and without liver injury were compared. Cox proportional hazards models were used to determine the variables that might have an effect on survival.
RESULTS: Among the 502 patients enrolled, 301 patients had abnormal liver function with increased neutrophil count, C-reactive protein, creatinine, troponin I (TnI), D-dimer, lactose dehydrogenase and creatine kinase. Patients with abnormal liver functions had a higher mortality rate (28.9% vs 9.0%, P < 0.001), a higher ratio of male sex (65.1% vs 40.8%, P < 0.001) and a higher chance of developing systemic inflammatory response syndrome (53.5% vs 41.3%, P = 0.007). Among patients with abnormal liver functions, patients with grade 2 liver damage (with both abnormal alanine aminotransferase or aspartate aminotransferase levels and abnormal alkaline phosphatase or gamma-glutamyl transpeptidase levels) had a higher ratio of male patients, elevated neutrophil count, procalcitonin, D-dimer levels and mortality rate. Multivariate Cox regression analyses suggested that the grade of liver damage (hazard ratio: 1.377, 95% confidence interval: 1.000-1.896, P = 0.049) was an independent predictor of death.
CONCLUSIONS: Patients with COVID-19 and abnormal liver functions have a higher mortality than those with normal liver functions. Liver damage is an independent prognostic factor of COVID-19.
© 2020 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  COVID-19; liver injury; prognosis

Mesh:

Substances:

Year:  2020        PMID: 32713118     DOI: 10.1111/1751-2980.12925

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  8 in total

1.  Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients.

Authors:  Jian Qu; Hai-Hong Zhu; Xue-Jian Huang; Ge-Fei He; Ji-Yang Liu; Juan-Juan Huang; Ying Chen; Qiang Qu; Ya-Li Wu; Xiang-Yu Chen; Qiong Lu
Journal:  Infect Drug Resist       Date:  2021-08-10       Impact factor: 4.003

Review 2.  Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19.

Authors:  Gergana Taneva; Dimitar Dimitrov; Tsvetelina Velikova
Journal:  World J Hepatol       Date:  2021-12-27

Review 3.  COVID-19: Gastrointestinal manifestations, liver injury and recommendations.

Authors:  Zulal Ozkurt; Esra Çınar Tanrıverdi
Journal:  World J Clin Cases       Date:  2022-02-06       Impact factor: 1.337

4.  Organ Involvement in COVID-19: A Molecular Investigation of Autopsied Patients.

Authors:  Prem Shankar; Jitendra Singh; Ankur Joshi; Anvita Gupta Malhotra; Arti Shrivas; Garima Goel; Priyal Gupta; Jayanthi Yadav; Saurabh Saigal; Sarman Singh; Shashank Purwar
Journal:  Microorganisms       Date:  2022-07-01

5.  Liver Function Tests and FIB-4 Score as Predictors of Severity in COVID-19 Patients from the South-West of Romania.

Authors:  Adina M Kamal; Florentina Dumitrescu; Adrian Mită; Denisa M Săbiescu; Dragoș O Alexandru; Codruța E Gheorghe; Monalisa M Filip; Adriana Ionescu-Ciocâlteu; Daniela T Maria; Diana Kamal; Constantin K Kamal
Journal:  Life (Basel)       Date:  2022-06-22

6.  A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients.

Authors:  Ruo Ran Wang; Min He; Yan Kang
Journal:  J Clin Lab Anal       Date:  2021-05-25       Impact factor: 2.352

Review 7.  Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.

Authors:  Dan-Dan Zhu; Xue-Mei Tan; Li-Qing Lu; Si-Jia Yu; Ru-Li Jian; Xin-Fang Liang; Yi-Xuan Liao; Wei Fan; Lucíia Barbier-Torres; Austin Yang; He-Ping Yang; Ting Liu
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

Review 8.  SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications.

Authors:  André Jefremow; Markus F Neurath
Journal:  Visc Med       Date:  2020-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.